Nina-Sophie Schmidt-Hegemann

7PUBLICATIONS
50CO-AUTHORS
Lexicography and semanticsPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 13, 2025
Assessing ChatGPT's Educational Potential in Lung Cancer Radiotherapy From Clinician and Patient Perspectives: Content Quality and Readability Analysis.

Cedric Richlitzki, Sina Mansoorian, Lukas Käsmann

|Sep 20, 2024
A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET-Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective Study.

Ali Janbain, Andrea Farolfi, Armelle Guenegou-Arnoux

|Mar 18, 2020
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy.

Marco M E Vogel, Stephanie G C Kroeze, Christoph Henkenberens

|Feb 01, 2020
Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective study.

N-S Schmidt-Hegemann, S G C Kroeze, C Henkenberens

|Mar 04, 2018
Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy.

Nina-Sophie Schmidt-Hegemann, Wolfgang Peter Fendler, Harun Ilhan

|Jan 20, 2018
Neoadjuvant chemoradiation for esophageal cancer : Surgery improves locoregional control while response based on FDG-PET/CT predicts survival.

Nina-Sophie Hegemann, Rebecca Koepple, Franziska Walter

Pageof 2

Frequent Collaborators

3 joint publications

Claus Belka

2 joint publications

Anca-Ligia Grosu

2 joint publications

Stephanie E Combs

2 joint publications

Christoph Henkenberens